Crossmark

Guillain–Barré syndrome in a cancer patient treated with bevacizumab

Crossref DOI link: https://doi.org/10.1007/s13691-018-0326-1

Published Online: 2018-05-02

Published Print: 2018-07

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Taguchi, Daiki

Kamada, Sachiko

Yoshida, Taichi

Fukuda, Koji

Shimazu, Kazuhiro

Inoue, Masahiro

Sugawara, Masashiro

Nanjyo, Hiroshi

Iijima, Katsunori

Shibata, Hiroyuki
License Information

Text and Data Mining valid from 2018-05-02
More Information

Article History

Received: 9 February 2018

Accepted: 3 April 2018

First Online: 2 May 2018

Compliance with ethical standards

:

: The authors declare that they have no potential conflict of interest.

: For this case report, formal consent is not required.